What question did this study set out to answer?

This research aims to evaluate the effectiveness of aminoguanidine in preventing diabetes-induced arterial wall protein changes.

June 27, 1986Science

Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial reveals aminoguanidine prevents arterial wall cross-linking in diabetic rats, suggesting a treatment option.

This research aims to evaluate the effectiveness of aminoguanidine in preventing diabetes-induced arterial wall protein changes.
Administered aminoguanidine to rats with induced diabetes
Measured formation of advanced glycosylation products and collagen cross-links in vitro and in vivo
Utilized fluorescent assays to quantify cross-linking and product formation
Aminoguanidine effectively inhibited advanced glycosylation product formation in vitro and in vivo, showing significant reduction in cross-linking (p<0.05)
In vivo administration resulted in lower arterial wall protein cross-linking compared to untreated controls (reduction rate of 40%)
Results suggest potential for aminoguanidine in treating chronic diabetic complications.

Brownlee et al. (1986) studied this question.

View Full Paper

Ask AI

Bookmark